Analyst firms · Bernstein · EMR
Bernstein EMR price target and rating history
Emerson Electric Company (EMR) · Technology
Bernstein rates Emerson Electric Company (EMR) Outperform with a $175 price target, as of its latest action on Jun 10, 2026. It has published 3 rating actions on EMR since January 2022, including 0 upgrades and 0 downgrades. Across 8 firms with a EMR price target in the last 12 months, the median target is $169. Bernstein's $175 is 4% above that.
- Current rating
- Outperform
- Price target
- $175
- Median target, all firms
- $169
- Actions on EMR
- 3
Bernstein price target on EMR
Every Bernstein rating on EMR
- Jun 10, 2026
- Aug 17, 2022
- Jan 11, 2022
How other firms rate EMR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| DA Davidson | Neutral | $145 | Jun 16, 2026 |
| Bernstein | Outperform | $175 | Jun 10, 2026 |
| Jefferies | Buy | $175 | Mar 31, 2026 |
| BMO Capital Markets | Market Perform | $150 | Mar 27, 2026 |
| Deutsche Bank | Hold | $170 | Feb 5, 2026 |
| Oppenheimer | Perform | Jan 27, 2026 | |
| TD Cowen | Hold | $150 | Jan 9, 2026 |
| UBS | Buy | $168 | Jan 5, 2026 |
| Evercore ISI | Outperform | $170 | Dec 15, 2025 |
Questions about Bernstein and EMR
- What is Bernstein's price target for EMR?
- Bernstein's latest stated price target for Emerson Electric Company (EMR) is $175, from its action on Jun 10, 2026.
- What is Bernstein's rating on EMR?
- Bernstein rates EMR Outperform, a bullish rating, as of Jun 10, 2026.
- When did Bernstein last change its view on EMR?
- On Jun 10, 2026, Bernstein starts coverage at Outperform, price target $175.
- How does Bernstein's EMR target compare with other analysts?
- Across 8 firms with a EMR price target in the last 12 months, the median target is $169. Bernstein's $175 is 4% above that.
More EMR rating histories
All Bernstein ratingsEMR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.